| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital [R. G., N. D., S. G., M. R.], and Departments of Surgery [R. G., S. G.] and Laboratory Medicine and Pathobiology [M. R.], The University of Toronto, Toronto, Ontario, M5G 1X5 Canada
The adenomatous polyposis coli (APC) gene is proposed to function as a gatekeeper of colorectal neoplasia. A germ-line variant of this gene, the APC I1307K allele, is present in
6% of the Ashkenazi Jewish population. To assess the role in tumorigenesis of the variant (A)8 tract produced by this allele, we undertook a somatic mutation analysis of the region surrounding codon 1307 in colorectal tumors from APC I1307K carriers. Somatic mutations involving the variant (A)3 tract were identified in 53 of 127 (42%) tumors from APC I1307K carriers compared with 5 of 127 (4%) mutations involving the wild-type allele of these tumors (P < 0.0001). Loss of heterozygosity of the wild-type allele was significantly more common in tumors with APC I1307K allele mutations (25 of 41, 61%) compared with APC I1307K carrier tumors without mutation of the variant (A)8 tract (12 of 53, 23%; P < 0.0005). This somatic biallelic APC inactivation further confirms the biological importance of the I1307K germ-line variant. The vast majority of APC I1307K somatic mutations consisted of a single adenine insertion (insA) involving the variant (A)8 tract. This insA mutation was mutually exclusive of the presence of microsatellite instability with 0 of 49 tumors with insA displaying BAT-26 instability compared with 9 of 78 tumors without insA (P = 0.01). These findings support a model where somatic instability of the (A)8 tract produced by the APC I1307K allele leads to increased APC gene inactivation and directly accounts for 42% of the colorectal neoplasms occurring in APC I1307K carriers.
1 This research was supported in part by the National Cancer Institute of Canada (to S. G. and M. R.) with funds provided by the Canadian Cancer Society. R. G. is a Terry Fox Research Fellow of the National Cancer Institute of Canada with funds provided by the Canadian Cancer Society.
2 To whom requests for reprints should be addressed, at Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Room 1073A, 600 University Avenue, Toronto, Ontario, M5G 1X5 Canada. E-mail: mredston@mtsinai.on.ca.
Received 4/29/98. Accepted 8/10/98.
This article has been cited by other articles:
![]() |
R A Kittles, A B Baffoe-Bonnie, T Y Moses, C M Robbins, C Ahaghotu, P Huusko, C Pettaway, S Vijayakumar, J Bennett, G Hoke, et al. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history J. Med. Genet., June 1, 2006; 43(6): 507 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Croitoru, S. P. Cleary, N. Di Nicola, M. Manno, T. Selander, M. Aronson, M. Redston, M. Cotterchio, J. Knight, R. Gryfe, et al. Association Between Biallelic and Monoallelic Germline MYH Gene Mutations and Colorectal Cancer Risk J Natl Cancer Inst, November 3, 2004; 96(21): 1631 - 1634. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Murphy, T. Geiger, M. J. Hafez, J. R. Eshleman, C. A. Griffin, and K. D. Berg A Single Nucleotide Primer Extension Assay to Detect the APC I1307K Gene Variant J. Mol. Diagn., November 1, 2003; 5(4): 222 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Syngal, D. Schrag, M. Falchuk, N. Tung, F. A. Farraye, D. Chung, M. Wright, A. Whetsell, G. Miller, and J. E. Garber Phenotypic Characteristics Associated With the APC Gene I1307K Mutation in Ashkenazi Jewish Patients With Colorectal Polyps JAMA, August 16, 2000; 284(7): 857 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kirchner, H. Tran, and M. A. Resnick A DNA Polymerase {epsilon} Mutant That Specifically Causes +1 Frameshift Mutations Within Homonucleotide Runs in Yeast Genetics, August 1, 2000; 155(4): 1623 - 1632. [Abstract] [Full Text] |
||||
![]() |
Z. Q. YUAN, N. WONG, W. D FOULKES, L. ALPERT, F. MANGANARO, C. ANDREUTTI-ZAUGG, R. IGGO, K. ANTHONY, E. HSIEH, M. REDSTON, et al. A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening J. Med. Genet., October 1, 1999; 36(10): 792 - 793. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |